Skip to main content

Iterum Therapeutics plc

ITRMDelisted Jun 23, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001659323

Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.

Q1 2026 vs. Q4 2025

How the institutions holding Iterum Therapeutics plc changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of ITRM: Q4 2025 compared with Q1 2026
MeasureQ4 2025Q1 2026Change
Holders2018−2
Shares1.67M1.41M−254.2K (−15.2%)
Value$557.9K$41.3K−$516.5K (−92.6%)

New holders (6)

Institutions that held Iterum Therapeutics plc at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to ITRM in Q1 2026
InstitutionSharesValue% of portfolio
HRT Financial LP890,083$26.0K0.00%
Jump Financial, LLC72,156$2.17K0.00%
XTX Topco Ltd49,380$1.48K0.00%
MAI Capital Management35,000$1.05K0.00%
Flagship Harbor Advisors, LLC20,000$6000.00%
Advisor Group Holdings, Inc.993$290.00%

Sold out (8)

Institutions that held Iterum Therapeutics plc at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of ITRM in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Apollon Financial, LLC630,250$211.1K
Jane Street Group, LLC289,410$97.0K
Alchemi Wealth, LLC268,886$90.1K
Virtu Financial LLC22,062$7.00K
Ground Swell Capital, LLC20,477$6.86K
Sanctuary Advisors, LLC20,000$6.70K
Geode Capital Management, LLC12,370$4.14K
SBI Securities Co., Ltd.16$5